Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jetton, T. L.
Right arrow Articles by Leahy, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jetton, T. L.
Right arrow Articles by Leahy, J. L.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:2294-2304, 2005
© 2005 by the American Diabetes Association, Inc.

Mechanisms of Compensatory ß-Cell Growth in Insulin-Resistant Rats

Roles of Akt Kinase

Thomas L. Jetton, James Lausier, Kyla LaRock, Winifred E. Trotman, Brooke Larmie, Aida Habibovic, Mina Peshavaria, and Jack L. Leahy

Division of Endocrinology, Diabetes, and Metabolism, University of Vermont, Burlington, Vermont

The physiological mechanisms underlying the compensatory growth of ß-cell mass in insulin-resistant states are poorly understood. Using the insulin-resistant Zucker fatty (fa/fa) (ZF) rat and the corresponding Zucker lean control (ZLC) rat, we investigated the factors contributing to the age-/obesity-related enhancement of ß-cell mass. A 3.8-fold ß-cell mass increase was observed in ZF rats as early as 5 weeks of age, an age that precedes severe insulin resistance by several weeks. Closer investigation showed that ZF rat pups were not born with heightened ß-cell mass but developed a modest increase over ZLC rats by 20 days that preceded weight gain or hyperinsulinemia that first developed at 24 days of age. In these ZF pups, an augmented survival potential of ß-cells of ZF pups was observed by enhanced activated (phospho-) Akt, phospho-BAD, and Bcl-2 immunoreactivity in the postweaning period. However, increased ß-cell proliferation in the ZF rats was only detected at 31 days of age, a period preceding massive ß-cell growth. During this phase, we also detected an increase in the numbers of small ß-cell clusters among ducts and acini, increased duct pancreatic/duodenal homeobox-1 (PDX-1) immunoreactivity, and an increase in islet number in the ZF rats suggesting duct- and acini-mediated heightened ß-cell neogenesis. Interestingly, in young ZF rats, specific cells associated with ducts, acini, and islets exhibited an increased frequency of PDX-1+/phospho-Akt+ staining, indicating a potential role for Akt in ß-cell differentiation. Thus, several adaptive mechanisms account for the compensatory growth of ß-cells in ZF rats, a combination of enhanced survival and neogenesis with a transient rise in proliferation before 5 weeks of age, with Akt serving as a potential mediator in these processes.

Address correspondence and reprint requests to T.L. Jetton, University of Vermont College of Medicine, Department of Medicine, Given C331, Burlington, VT 05405. E-mail: thomas.jetton{at}.uvm.edu

Key Words: IRS-2, insulin receptor substrate-2 • PDX-1, pancreatic/duodenal homeobox-1 • PKB, protein kinase B


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
J. L. Leahy
Mary, Mary, Quite Contrary, How Do Your {beta}-Cells Fail?
Diabetes, October 1, 2008; 57(10): 2563 - 2564.
[Full Text] [PDF]

Home page
 DiabetesHome page
D. K. Hagman, M. G. Latour, S. K. Chakrabarti, G. Fontes, J. Amyot, C. Tremblay, M. Semache, J. A. Lausier, V. Roskens, R. G. Mirmira, et al.
Cyclical and Alternating Infusions of Glucose and Intralipid in Rats Inhibit Insulin Gene Expression and Pdx-1 Binding in Islets
Diabetes, February 1, 2008; 57(2): 424 - 431.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. A. Menge, A. Tannapfel, O. Belyaev, R. Drescher, C. Muller, W. Uhl, W. E. Schmidt, and J. J. Meier
Partial Pancreatectomy in Adult Humans Does Not Provoke -Cell Regeneration
Diabetes, January 1, 2008; 57(1): 142 - 149.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. Yano, Z. Liu, J. Donovan, M. K. Thomas, and J. F. Habener
Stromal Cell Derived Factor-1 (SDF-1)/CXCL12 Attenuates Diabetes in Mice and Promotes Pancreatic {beta}-Cell Survival by Activation of the Prosurvival Kinase Akt
Diabetes, December 1, 2007; 56(12): 2946 - 2957.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
S. Park, S. M. Hong, J. E. Lee, and S. R. Sung
Exercise improves glucose homeostasis that has been impaired by a high-fat diet by potentiating pancreatic beta-cell function and mass through IRS2 in diabetic rats
J Appl Physiol, November 1, 2007; 103(5): 1764 - 1771.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Mussmann, M. Geese, F. Harder, S. Kegel, U. Andag, A. Lomow, U. Burk, D. Onichtchouk, C. Dohrmann, and M. Austen
Inhibition of GSK3 Promotes Replication and Survival of Pancreatic Beta Cells
J. Biol. Chem., April 20, 2007; 282(16): 12030 - 12037.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. G. Latour, T. Alquier, E. Oseid, C. Tremblay, T. L. Jetton, J. Luo, D. C.-H. Lin, and V. Poitout
GPR40 Is Necessary but Not Sufficient for Fatty Acid Stimulation of Insulin Secretion In Vivo
Diabetes, April 1, 2007; 56(4): 1087 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C. L. Kien, R. Blauwiekel, J. Y. Bunn, T. L. Jetton, W. L. Frankel, and J. J. Holst
Cecal Infusion of Butyrate Increases Intestinal Cell Proliferation in Piglets
J. Nutr., April 1, 2007; 137(4): 916 - 922.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Peshavaria, B. L. Larmie, J. Lausier, B. Satish, A. Habibovic, V. Roskens, K. LaRock, B. Everill, J. L. Leahy, and T. L. Jetton
Regulation of Pancreatic {beta}-Cell Regeneration in the Normoglycemic 60% Partial-Pancreatectomy Mouse
Diabetes, December 1, 2006; 55(12): 3289 - 3298.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
W. Wente, A. M. Efanov, M. Brenner, A. Kharitonenkov, A. Koster, G. E. Sandusky, S. Sewing, I. Treinies, H. Zitzer, and J. Gromada
Fibroblast Growth Factor-21 Improves Pancreatic {beta}-Cell Function and Survival by Activation of Extracellular Signal-Regulated Kinase 1/2 and Akt Signaling Pathways
Diabetes, September 1, 2006; 55(9): 2470 - 2478.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. Robertson, J. J. Kopchick, and J.-L. Liu
Growth hormone receptor gene deficiency causes delayed insulin responsiveness in skeletal muscles without affecting compensatory islet cell overgrowth in obese mice
Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E491 - E498.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
S. B. Choi, J. S. Jang, S. M. Hong, D. W. Jun, and S. Park
Exercise and dexamethasone oppositely modulate {beta}-cell function and survival via independent pathways in 90% pancreatectomized rats.
J. Endocrinol., August 1, 2006; 190(2): 471 - 482.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.